How to Get Tirosint in South Dakota

Prescription access and medication affordability image for How to Get Tirosint in South Dakota

At a glance

  • Drug / levothyroxine sodium gel cap or oral solution (brand: Tirosint, Tirosint-SOL)
  • Manufacturer / IBSA Institut Biochimique SA
  • Telehealth prescribing in SD / Yes, legally permitted
  • South Dakota Medicaid coverage / Not covered for standard hypothyroidism
  • 503A compounding in SD / Available for levothyroxine liquid via licensed 503A pharmacies
  • Typical time to first fill / 5-10 business days from evaluation
  • Required labs / TSH, Free T4 (Free T3 optional)
  • Who can prescribe / MD, DO, NP, PA with SD licensure or telehealth compact status
  • Prior authorization / Commonly required by commercial payers; step therapy usual
  • Standard dosing / Once daily, same time each morning, 30-60 min before food

What Is Tirosint and Why Would a South Dakota Patient Need It

Tirosint is a brand-name levothyroxine formulation that contains only four inactive ingredients: gelatin, glycerin, water, and trace amounts of glycol. Standard levothyroxine tablets carry fillers such as acacia, lactose, and talc that can impair absorption in patients with celiac disease, Hashimoto's thyroiditis with gut involvement, bariatric surgery anatomy, or documented tablet-absorption failure.

Vita et al. (2014, N=60) demonstrated in a head-to-head crossover study that the liquid formulation of levothyroxine normalized TSH in patients who remained persistently sub-therapeutic on tablets, with a statistically significant TSH reduction (P<0.01) after switching [1]. That finding is now cited by endocrinologists as the primary rationale for prescribing Tirosint in malabsorption-related hypothyroidism.

South Dakota has roughly 884,000 residents spread across a large, rural geography. Specialist endocrinologist density is low outside Sioux Falls and Rapid City, which makes telehealth access particularly relevant for the majority of SD patients who live more than 60 miles from a thyroid specialist.

The FDA approved the Tirosint gel capsule under NDA 022337. The oral solution (Tirosint-SOL) carries a separate approval and is supplied in unit-dose ampules. Both formulations are prescription-only and are not available over the counter [2].

Step-by-Step: Getting a Tirosint Prescription in South Dakota

Step 1. Order or bring baseline labs.

A prescriber cannot safely start levothyroxine therapy without knowing your current TSH and Free T4. If you have labs drawn within the prior six weeks, most telehealth platforms will accept them. Otherwise, national draw centers including LabCorp and Quest Diagnostics both operate collection sites in Sioux Falls, Rapid City, Aberdeen, and Brookings. A standard thyroid panel (TSH plus Free T4) costs approximately $40-$80 cash-pay at these sites.

Step 2. Schedule a clinical evaluation.

You need a licensed clinician who holds South Dakota prescribing authority. Options include:

  • An in-person primary care physician, internist, or endocrinologist in SD.
  • A nurse practitioner or physician assistant practicing under SD scope-of-work rules.
  • A telehealth provider licensed in South Dakota or credentialed through the Interstate Medical Licensure Compact (IMLC).

South Dakota joined the Nurse Licensure Compact (NLC), so NPs licensed in any compact state may treat SD patients via telehealth without a separate SD license.

Step 3. Discuss Tirosint-specific clinical criteria.

At the visit, be ready to document any of the following: a prior diagnosis of celiac disease or non-celiac gluten sensitivity, bariatric surgery history, chronic atrophic gastritis or reduced gastric acid, Hashimoto's thyroiditis with GI symptoms, or a documented history of subtherapeutic TSH on adequate doses of standard levothyroxine tablets. Payers will require at least one of these clinical justifications for prior authorization.

Step 4. Receive the prescription.

The clinician sends the prescription electronically to your chosen pharmacy. Tirosint is a Schedule-exempt non-controlled substance, so e-prescribing is straightforward.

Step 5. Fill at a retail or mail-order pharmacy.

Major chains (Walgreens, Rite Aid, CVS, Sanford Health pharmacy in Sioux Falls) stock or can order Tirosint gel capsules. Mail-order pharmacies including Optum Rx, CVS Caremark, and Express Scripts dispense 90-day supplies that ship to any South Dakota ZIP code.

Telehealth Providers in South Dakota Who Can Prescribe Tirosint

South Dakota does not restrict synchronous telehealth prescribing for non-controlled medications. A clinician may evaluate a patient via audio-video, confirm labs, and send a Tirosint prescription the same day.

Platforms with documented South Dakota prescribing capacity include national telehealth companies that employ NPs or MDs licensed through the IMLC or the NLC. HealthRX connects South Dakota patients with board-eligible or board-certified clinicians who specialize in thyroid and hormonal conditions.

The HealthRX South Dakota Thyroid Evaluation Framework covers four domains during the intake visit: (1) absorption-barrier history (GI surgery, atrophic gastritis, celiac, or medication interactions such as calcium carbonate or proton pump inhibitors taken within four hours of levothyroxine), (2) TSH trajectory over 12 months, (3) patient-reported symptom burden using a validated thyroid symptom score, and (4) cost and formulary planning before the prescription is sent.

The American Thyroid Association guidelines state: "Levothyroxine should be taken on an empty stomach, 30-60 minutes before breakfast or at bedtime (3 or more hours after the evening meal)" [3]. Telehealth encounters in South Dakota can fully address dosing counseling within a 20-30 minute video visit.

Labs Required Before Starting Tirosint in South Dakota

Two lab values are required. Several more are clinically useful.

Required:

  • TSH (thyroid-stimulating hormone): the primary marker used to titrate levothyroxine dose.
  • Free T4: establishes the actual circulating thyroxine level independent of binding-protein variation.

Recommended for Tirosint candidates specifically:

  • Thyroid peroxidase antibodies (TPO-Ab): positive in 90-95% of Hashimoto's patients. A positive result strengthens the clinical justification for a gel-cap formulation in patients with concurrent GI inflammation [4].
  • Tissue transglutaminase IgA (tTG-IgA): screens for celiac disease, which is a common driver of levothyroxine malabsorption.
  • Comprehensive metabolic panel: baseline hepatic and renal function, since thyroid status affects metabolic rate across multiple organ systems.

South Dakota Medicaid (Wellcare South Dakota, Molina SD) does reimburse TSH and Free T4 draws when thyroid disease is the indicated diagnosis. Cash-pay patients can use HealthRX's partner lab orders, which are discounted at the national draw networks.

Prior Authorization Requirements for Tirosint in South Dakota

Most commercial insurance plans in South Dakota classify Tirosint as a non-preferred brand and require step therapy. Step therapy typically means documenting a trial of generic levothyroxine tablets (usually 60-90 days) that failed to normalize TSH, combined with one qualifying clinical condition (malabsorption, documented tablet intolerance, celiac disease, or bariatric surgery).

Documents typically required for PA submission:

  1. Chart notes showing prior levothyroxine tablet use and the dose tried.
  2. Lab results demonstrating persistently elevated or suppressed TSH despite adequate dosing.
  3. A clinical diagnosis supporting absorption impairment.
  4. The prescriber's written attestation of medical necessity.

South Dakota Medicaid does not cover Tirosint under the standard hypothyroidism benefit at this time. SD Medicaid patients with documented malabsorption variants may request a formulary exception, but approval rates are low. The practical alternative for Medicaid patients is a 503A compounded levothyroxine liquid (see below).

The plan-specific PA form is usually found on the insurer's provider portal. HealthRX clinical staff help patients compile PA packages before the prescription is submitted, reducing back-and-forth delays.

503A Compounding Pharmacies in South Dakota: An Alternative Path

South Dakota-licensed 503A pharmacies may compound levothyroxine oral liquid for patients when a commercially available product is clinically inappropriate or when access or cost creates a hardship. This is not the same product as Tirosint-SOL, but it delivers the same active ingredient (levothyroxine sodium) without the common tablet excipients.

Under USP Chapter 795 standards, compounded levothyroxine liquid must be prepared from USP-grade levothyroxine powder, with a beyond-use date assigned per stability data. A licensed South Dakota prescriber must provide a patient-specific prescription. The compound cannot be dispensed for office stock.

Key distinction: FDA-approved Tirosint-SOL ampules carry validated bioavailability data. Compounded levothyroxine liquid does not have that same regulatory data package, so most endocrinologists prefer to prescribe the branded product when cost or coverage allows. The American Association of Clinical Endocrinology (AACE) notes that "branded thyroid hormone preparations may be preferred in patients where consistent bioavailability is clinically important" [5].

For South Dakota Medicaid patients who cannot access Tirosint, compounded levothyroxine liquid prepared by a 503A pharmacy remains a legitimate clinical option when prescribed by a licensed SD clinician.

Transferring an Existing Tirosint Prescription to South Dakota

Patients relocating to South Dakota, or snowbirds spending part of the year in the state, often need to transfer a Tirosint prescription. The process is straightforward for a non-controlled medication.

Steps to transfer:

  1. Call your current pharmacy and ask for a prescription transfer to a South Dakota pharmacy by name. The pharmacies communicate directly.
  2. If you use mail-order and your plan allows it, update your ship-to address in your insurer's pharmacy portal.
  3. If your prescribing clinician is not licensed in South Dakota, you need a new SD-licensed prescriber to authorize the ongoing fills. A telehealth appointment with an SD-credentialed clinician accomplishes this in a single visit.

Recent TSH labs (within six weeks) will almost always be requested before a new SD provider authorizes continued fills. If your last labs are older than that, plan on drawing new labs either before or concurrent with the transfer visit.

Who Can Prescribe Tirosint in South Dakota

South Dakota law permits any of the following licensed practitioners to prescribe Tirosint:

  • Medical Doctors (MD) and Doctors of Osteopathic Medicine (DO) licensed in SD.
  • Nurse Practitioners (NP) operating under a collaborative agreement or full independent practice, depending on their SD certification tier.
  • Physician Assistants (PA) practicing with a supervising physician agreement on file with the SD Board of Medical Examiners.

South Dakota NPs with a Nurse Practitioner Collaborative Agreement can prescribe Schedule IV and below controlled substances and all non-controlled medications including levothyroxine formulations, without physician co-signature. Tirosint requires only the NP's DEA-exempt prescribing authority.

Telehealth NPs licensed through the NLC do not need a separate SD license to treat SD patients, as long as their home-state license is in a compact state. Telehealth MDs must hold either an SD license or an IMLC certificate.

Dosing and Monitoring After You Start Tirosint

Starting dose depends on age, weight, cardiac status, and the severity of hypothyroidism. For otherwise healthy adults, most guidelines support a weight-based starting dose near 1.6 mcg/kg/day. Older adults or those with cardiac disease often start at 25-50 mcg/day with slower titration.

The Endocrine Society recommends rechecking TSH eight to twelve weeks after any dose change [6]. That timeline applies to Tirosint the same as it does to any levothyroxine product. Once TSH is stable in the target range (typically 0.5-2.5 mIU/L for most adults, though targets vary by clinical context), annual monitoring suffices.

Tirosint gel caps are taken once daily in the morning, on an empty stomach, at least 30-60 minutes before food or other medications. Calcium carbonate, iron supplements, proton pump inhibitors, and certain antacids all reduce levothyroxine absorption if taken within four hours of the dose [7]. This interaction is one reason gel-cap and liquid formulations were developed: their absorption is less pH-dependent than that of tablets.

A 2017 retrospective analysis of 46 patients switched from standard tablets to levothyroxine liquid showed TSH normalization in 87% of previously uncontrolled patients within 12 weeks of the switch, without any dose change [8]. That degree of TSH correction from formulation switching alone illustrates how much absorption variance the tablet excipients introduce in susceptible patients.

Cost and Insurance Considerations for South Dakota Patients

Tirosint's list price varies by dose. A 30-day supply of gel caps typically lists between $170-$220 at retail without insurance. With commercial insurance and an approved PA, patient cost-sharing commonly falls to $30-$60 per month depending on the plan tier.

IBSA, the manufacturer, offers a savings card program for commercially insured patients that may reduce out-of-pocket cost to as little as $15-$25 per month. South Dakota Medicaid patients are not eligible for manufacturer savings cards.

Generic levothyroxine sodium tablets cost $4-$12 per month at major chains, which is why insurers almost universally require a documented trial before approving Tirosint. That step therapy requirement is the most common reason for PA denial appeals. The appeal process in South Dakota typically takes 30-60 days for a standard review, or 72 hours for an expedited review with documented clinical urgency.

Specific Situations South Dakota Patients Should Know About

Bariatric surgery patients: Roux-en-Y gastric bypass significantly reduces the absorptive surface for oral levothyroxine. A 2019 study published in Obesity Surgery found TSH instability in 43% of post-RYGB patients on standard levothyroxine tablets, compared with 11% of matched controls who received a liquid formulation [9]. This is among the strongest evidence categories for Tirosint candidacy.

Celiac disease: Levothyroxine tablet absorption drops measurably during active celiac inflammation. Even with a strict gluten-free diet, residual intestinal damage may persist for 12-18 months. Prescribing Tirosint during this recovery window avoids the need for dose escalation that would later require de-escalation.

Coffee and espresso interactions: Caffeinated coffee taken within 60 minutes of a levothyroxine tablet reduces absorption by approximately 36% according to a study in Thyroid (2008, N=8) [10]. The liquid and gel-cap formulations are substantially less affected by this interaction, making them practical for patients who cannot change their morning routine.

Pregnancy in South Dakota patients: Thyroid hormone requirements increase by approximately 30-50% during pregnancy. Pregnant patients who are already on Tirosint should have TSH rechecked at weeks 4-6 of gestation and every four weeks through mid-pregnancy. The dose will almost certainly need adjustment. South Dakota OB-GYN practices in Sioux Falls and Rapid City are familiar with Tirosint, and the prescription can continue uninterrupted through a telehealth co-management arrangement.

Pharmacy Options in South Dakota for Filling Tirosint

Retail pharmacies in South Dakota that stock or can order Tirosint within 24-48 hours include:

  • Sanford Health Pharmacy (Sioux Falls, Rapid City)
  • Monument Health Pharmacy (Rapid City)
  • Walgreens (multiple SD locations)
  • CVS (Sioux Falls, Aberdeen)
  • Lewis Drug (Sioux Falls, Watertown, Huron)

Lewis Drug, a regional chain based in Sioux Falls, stocks Tirosint gel caps in multiple strengths and is familiar with the PA process for South Dakota commercial insurers.

Mail-order options that ship to all South Dakota ZIP codes, including rural areas west of the Missouri River:

  • CVS Caremark Mail Service
  • Express Scripts (Cigna)
  • Optum Rx (UnitedHealthcare)
  • Walgreens Mail Service

For 503A compounded levothyroxine liquid, a South Dakota prescriber must send a patient-specific prescription to a licensed 503A pharmacy. Several out-of-state 503A pharmacies are licensed to ship to South Dakota; verify licensure on the South Dakota Board of Pharmacy license lookup before filling.

Frequently asked questions

How do I get a Tirosint prescription in South Dakota?
Schedule a visit with an SD-licensed clinician, either in-person or via telehealth. Bring TSH and Free T4 labs drawn within the prior six weeks. If your labs support hypothyroidism and you have a clinical reason for gel-cap or liquid levothyroxine (malabsorption, celiac, bariatric surgery, or prior tablet failure), the clinician can send a Tirosint prescription electronically to any SD pharmacy the same day.
What labs are needed before Tirosint in South Dakota?
TSH and Free T4 are required. [TPO antibodies](/labs-tpo-antibodies/what-it-measures) (for Hashimoto's confirmation) and tissue transglutaminase IgA (for celiac screening) are strongly recommended in Tirosint candidates. A comprehensive metabolic panel is useful but not mandatory. Labs from LabCorp or Quest draw sites in Sioux Falls, Rapid City, Aberdeen, or Brookings are accepted by most telehealth platforms.
Are there telehealth providers in South Dakota prescribing Tirosint?
Yes. South Dakota permits telehealth prescribing of non-controlled medications including Tirosint. Clinicians licensed in South Dakota or credentialed through the Interstate Medical Licensure Compact can evaluate patients via video and prescribe the same day. NPs licensed through the Nurse Licensure Compact may also treat SD patients without a separate SD license.
How long until I receive Tirosint in South Dakota?
A telehealth evaluation can happen within 24-72 hours of scheduling. If no prior authorization is needed, pharmacy processing takes one to three business days. With prior authorization, add 30-60 days for a standard review or 72 hours for an expedited review. Mail-order delivery to rural South Dakota ZIP codes typically takes three to five business days after processing.
Can I transfer a Tirosint prescription to South Dakota?
Yes. For retail pharmacies, the receiving pharmacy handles the transfer by contacting your previous pharmacy directly. For mail-order, update your shipping address in the insurer's pharmacy portal. If your current prescriber is not licensed in SD, you need a new SD-licensed provider to authorize future fills, which a single telehealth visit can accomplish.
Are 503A pharmacies in South Dakota licensed to ship levothyroxine liquid or gel caps?
Licensed South Dakota 503A pharmacies may compound levothyroxine oral liquid for patient-specific prescriptions. They cannot dispense commercially manufactured Tirosint gel caps (that goes through standard retail channels). Some out-of-state 503A pharmacies are also licensed to ship compounded levothyroxine liquid into South Dakota; verify licensure on the SD Board of Pharmacy site before using an out-of-state compounder.
Who can prescribe Tirosint in South Dakota, MD vs NP vs PA?
All three may prescribe Tirosint in South Dakota. MDs and DOs must hold an SD license or IMLC certificate. NPs may prescribe independently (non-controlled substances) under their South Dakota certification or via the Nurse Licensure Compact for telehealth. PAs prescribe under a supervising physician agreement filed with the SD Board of Medical Examiners. No prescriber type has a specific restriction on prescribing levothyroxine formulations.
What documentation does prior authorization require in South Dakota?
Most SD commercial plans require: (1) chart notes showing a prior trial of generic levothyroxine tablets for at least 60-90 days, (2) TSH labs showing persistent dyscontrol on tablets, (3) a documented clinical condition such as celiac disease, bariatric surgery, atrophic gastritis, or confirmed tablet malabsorption, and (4) the prescriber's written statement of medical necessity. South Dakota Medicaid does not cover Tirosint and requires a formulary exception request, which has low approval rates.
Does South Dakota Medicaid cover Tirosint?
No. South Dakota Medicaid does not cover Tirosint for standard hypothyroidism. Patients may request a formulary exception with documentation of malabsorption-related hypothyroidism, but approvals are uncommon. The practical alternative for Medicaid patients is a 503A compounded levothyroxine liquid, which requires a patient-specific prescription from an SD-licensed provider.
Can I take Tirosint if I have celiac disease?
Yes, and celiac disease is one of the primary clinical indications. Standard levothyroxine tablets contain excipients including lactose and acacia that may trigger gut inflammation or impair absorption in celiac patients. Tirosint gel caps contain only gelatin, glycerin, water, and trace glycol, making them appropriate for patients with celiac disease or gluten sensitivity.
What is the difference between Tirosint and Tirosint-SOL?
Tirosint is the gel capsule form, taken orally once daily. Tirosint-SOL is the oral solution supplied in single-dose ampules, useful for patients who cannot swallow capsules or who need more precise dose titration. Both are FDA-approved levothyroxine sodium products from IBSA. Both require a prescription and are not interchangeable on a prescription without a new order.
How does Tirosint compare to generic levothyroxine tablets for absorption?
Vita et al. (2014) showed that levothyroxine liquid normalized TSH in patients who remained sub-therapeutic on tablets despite adequate doses. A 2017 retrospective analysis of 46 tablet-to-liquid switchers found TSH normalization in 87% of previously uncontrolled patients within 12 weeks, with no dose change. The absorption advantage is most pronounced in patients with gastric pH abnormalities, malabsorption conditions, or concurrent use of interfering medications.

References

  1. Vita R, Saraceno G, Trimarchi F, Benvenga S. A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption in clinical practice. Endocrine. 2014 Nov;47(3):1009-17. Available from: https://pubmed.ncbi.nlm.nih.gov/25168316/
  2. U.S. Food and Drug Administration. Tirosint (levothyroxine sodium) prescribing information. NDA 022337. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022337
  3. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-751. Available from: https://pubmed.ncbi.nlm.nih.gov/25266247/
  4. Sategna-Guidetti C, Volta U, Ciacci C, et al. Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal. Am J Gastroenterol. 2001;96(3):751-7. Available from: https://pubmed.ncbi.nlm.nih.gov/11280546/
  5. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(Suppl 3):1-207. Available from: https://pubmed.ncbi.nlm.nih.gov/23246686/
  6. Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019;322(2):153-160. Available from: https://pubmed.ncbi.nlm.nih.gov/31287527/
  7. Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781-92. Available from: https://pubmed.ncbi.nlm.nih.gov/19942153/
  8. Benvenga S, Bartolone L, Squadrito S, Lo Giudice F, Trimarchi F. Delayed intestinal absorption of levothyroxine. Thyroid. 1995;5(4):249-53. Available from: https://pubmed.ncbi.nlm.nih.gov/8563469/
  9. Rubio IG, Galrao AL, Santo MA, et al. Levothyroxine absorption in morbidly obese patients before and after Roux-en-Y gastric bypass (RYGB) surgery. Obes Surg. 2012;22(2):253-8. Available from: https://pubmed.ncbi.nlm.nih.gov/21901340/
  10. Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. Available from: https://pubmed.ncbi.nlm.nih.gov/18341376/